STIC consensus statement on immunotherapy for the treatment of multiple myeloma
SITC convened an expert panel, which met to consider the current role of approved and emerging immunotherapy agents in MM and provide guidance to the oncology community by developing consensus recommendations. As immunotherapy evolves as a therapeutic option for the treatment of MM, these guidelines will be updated.
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommend...
The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT's scientific council and board.
Management of adults and children undergoing chimeric antigen receptor T-cell th...
Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). These recommendations are not prescriptive and are intended as guidance in the use of this novel therapeutic class.